BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35105893)

  • 1. SARS-CoV-2 genomes from Saudi Arabia implicate nucleocapsid mutations in host response and increased viral load.
    Mourier T; Shuaib M; Hala S; Mfarrej S; Alofi F; Naeem R; Alsomali A; Jorgensen D; Subudhi AK; Ben Rached F; Guan Q; Salunke RP; Ooi A; Esau L; Douvropoulou O; Nugmanova R; Perumal S; Zhang H; Rajan I; Al-Omari A; Salih S; Shamsan A; Al Mutair A; Taha J; Alahmadi A; Khotani N; Alhamss A; Mahmoud A; Alquthami K; Dageeg A; Khogeer A; Hashem AM; Moraga P; Volz E; Almontashiri N; Pain A
    Nat Commun; 2022 Feb; 13(1):601. PubMed ID: 35105893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleocapsid mutations R203K/G204R increase the infectivity, fitness, and virulence of SARS-CoV-2.
    Wu H; Xing N; Meng K; Fu B; Xue W; Dong P; Tang W; Xiao Y; Liu G; Luo H; Zhu W; Lin X; Meng G; Zhu Z
    Cell Host Microbe; 2021 Dec; 29(12):1788-1801.e6. PubMed ID: 34822776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
    Johnson BA; Zhou Y; Lokugamage KG; Vu MN; Bopp N; Crocquet-Valdes PA; Kalveram B; Schindewolf C; Liu Y; Scharton D; Plante JA; Xie X; Aguilar P; Weaver SC; Shi PY; Walker DH; Routh AL; Plante KS; Menachery VD
    PLoS Pathog; 2022 Jun; 18(6):e1010627. PubMed ID: 35728038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary dynamics of SARS-CoV-2 nucleocapsid protein and its consequences.
    Rahman MS; Islam MR; Alam ASMRU; Islam I; Hoque MN; Akter S; Rahaman MM; Sultana M; Hossain MA
    J Med Virol; 2021 Apr; 93(4):2177-2195. PubMed ID: 33095454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
    Franco-Muñoz C; Álvarez-Díaz DA; Laiton-Donato K; Wiesner M; Escandón P; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Nov; 85():104557. PubMed ID: 32950697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phylogenomics and population genomics of SARS-CoV-2 in Mexico during the pre-vaccination stage reveals variants of interest B.1.1.28.4 and B.1.1.222 or B.1.1.519 and the nucleocapsid mutation S194L associated with symptoms.
    Barona-Gómez F; Delaye L; Díaz-Valenzuela E; Plisson F; Cruz-Pérez A; Díaz-Sánchez M; García-Sepúlveda CA; Sanchez-Flores A; Pérez-Abreu R; Valencia-Valdespino FJ; Vega-Magaña N; Muñoz-Valle JF; García-González OP; Bernal-Silva S; Comas-García A; Cibrián-Jaramillo A
    Microb Genom; 2021 Nov; 7(11):. PubMed ID: 34846283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2, the pandemic coronavirus: Molecular and structural insights.
    Kadam SB; Sukhramani GS; Bishnoi P; Pable AA; Barvkar VT
    J Basic Microbiol; 2021 Mar; 61(3):180-202. PubMed ID: 33460172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
    Nguyen A; Zhao H; Myagmarsuren D; Srinivasan S; Wu D; Chen J; Piszczek G; Schuck P
    Elife; 2024 Jun; 13():. PubMed ID: 38941236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic RNA Elements Drive Phase Separation of the SARS-CoV-2 Nucleocapsid.
    Iserman C; Roden CA; Boerneke MA; Sealfon RSG; McLaughlin GA; Jungreis I; Fritch EJ; Hou YJ; Ekena J; Weidmann CA; Theesfeld CL; Kellis M; Troyanskaya OG; Baric RS; Sheahan TP; Weeks KM; Gladfelter AS
    Mol Cell; 2020 Dec; 80(6):1078-1091.e6. PubMed ID: 33290746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
    Khan MT; Zeb MT; Ahsan H; Ahmed A; Ali A; Akhtar K; Malik SI; Cui Z; Ali S; Khan AS; Ahmad M; Wei DQ; Irfan M
    Arch Microbiol; 2021 Jan; 203(1):59-66. PubMed ID: 32749662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A computational approach to design potential siRNA molecules as a prospective tool for silencing nucleocapsid phosphoprotein and surface glycoprotein gene of SARS-CoV-2.
    Chowdhury UF; Sharif Shohan MU; Hoque KI; Beg MA; Sharif Siam MK; Moni MA
    Genomics; 2021 Jan; 113(1 Pt 1):331-343. PubMed ID: 33321203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
    Zhou J; Zhou Y; Wei XF; Fan L; Gao X; Li Y; Wu Y; Feng W; Shen X; Liu L; Xu G; Zhang Z
    J Med Virol; 2024 Mar; 96(3):e29531. PubMed ID: 38515377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2 Viral Genome and Viral Nucleocapsid in Various Organs and Systems.
    Oprinca GC; Mohor CI; Bereanu AS; Oprinca-Muja LA; Bogdan-Duică I; Fleacă SR; Hașegan A; Diter A; Boeraș I; Cristian AN; Tâlvan ET; Mohor CI
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    Benvenuto D; Demir AB; Giovanetti M; Bianchi M; Angeletti S; Pascarella S; Cauda R; Ciccozzi M; Cassone A
    J Med Virol; 2020 Oct; 92(10):2232-2237. PubMed ID: 32492183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral MicroRNAs Encoded by Nucleocapsid Gene of SARS-CoV-2 Are Detected during Infection, and Targeting Metabolic Pathways in Host Cells.
    Meng F; Siu GK; Mok BW; Sun J; Fung KSC; Lam JY; Wong NK; Gedefaw L; Luo S; Lee TMH; Yip SP; Huang CL
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactomes of SARS-CoV-2 and human coronaviruses reveal host factors potentially affecting pathogenesis.
    Chen Z; Wang C; Feng X; Nie L; Tang M; Zhang H; Xiong Y; Swisher SK; Srivastava M; Chen J
    EMBO J; 2021 Sep; 40(17):e107776. PubMed ID: 34232536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.